| scholarly article | Q13442814 |
| P2093 | author name string | Lu Wang | |
| Zhenggang Zhu | |||
| Xuehua Chen | |||
| Junqing Wang | |||
| Zhou Yunyun | |||
| P2860 | cites work | A multidrug resistance transporter from human MCF-7 breast cancer cells | Q22008574 |
| Global cancer statistics | Q22241238 | ||
| Probiotics against neoplastic transformation of gastric mucosa: effects on cell proliferation and polyamine metabolism | Q26825488 | ||
| Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells | Q28264780 | ||
| The role of ABC transporters in drug resistance, metabolism and toxicity | Q28283237 | ||
| Critical appraisal of the side population assay in stem cell and cancer stem cell research | Q28304721 | ||
| BCRP/ABCG2 inhibition sensitizes hepatocellular carcinoma cells to sorafenib | Q28538126 | ||
| Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells | Q33317848 | ||
| Evolutionary analyses of ABC transporters of Dictyostelium discoideum | Q33903779 | ||
| Transport in technicolor: mapping ATP-binding cassette transporters in sea urchin embryos. | Q34173709 | ||
| ABCG2 transports and transfers heme to albumin through its large extracellular loop | Q34236666 | ||
| Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates | Q34446056 | ||
| ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells. | Q34505177 | ||
| ABC transporters in Dictyostelium discoideum development | Q34962395 | ||
| Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response | Q36353020 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| ABC transporters, neural stem cells and neurogenesis--a different perspective | Q36646747 | ||
| Novel insights into targeting ATP-binding cassette transporters for antitumor therapy | Q37916651 | ||
| CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways | Q38932140 | ||
| CRKL protein overexpression enhances cell proliferation and invasion in pancreatic cancer | Q38947639 | ||
| Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer | Q39384371 | ||
| Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. | Q39855572 | ||
| Identification of gastric cancer stem cells using the cell surface marker CD44. | Q39856772 | ||
| Crk and CrkL adaptor proteins: networks for physiological and pathological signaling | Q41942048 | ||
| CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126. | Q42268045 | ||
| Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. | Q43739398 | ||
| Epigenetics of cancer stem cells: Pathways and therapeutics. | Q51051931 | ||
| Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2. | Q54318298 | ||
| Mutagenicity testing | Q68226123 | ||
| Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery | Q85778616 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biostatistics | Q214746 |
| P304 | page(s) | 5256-5267 | |
| P577 | publication date | 2016-12-23 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | ABCG2 confers promotion in gastric cancer through modulating downstream CRKL in vitro combining with biostatistics mining | |
| P478 | volume | 8 |
| Q99551775 | Effect of sodium butyrate on ABC transporters in lung cancer A549 and colorectal cancer HCT116 cells |
| Q91755761 | Effects of histone deacetylase inhibitors on ATP-binding cassette transporters in lung cancer A549 and colorectal cancer HCT116 cells |
| Q52649728 | Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway. |
Search more.